These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 29266502)

  • 1. Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis.
    Baschat AA; Dewberry D; Seravalli V; Miller JL; Block-Abraham D; Blitzer MG
    Ultrasound Obstet Gynecol; 2018 Dec; 52(6):728-733. PubMed ID: 29266502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study.
    Scazzocchio E; Oros D; Diaz D; Ramirez JC; Ricart M; Meler E; González de Agüero R; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):435-441. PubMed ID: 27807890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.
    Yu CK; Papageorghiou AT; Parra M; Palma Dias R; Nicolaides KH;
    Ultrasound Obstet Gynecol; 2003 Sep; 22(3):233-9. PubMed ID: 12942493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of early supplementation with low-dose aspirin on functional first trimester parameters in low-risk pregnancies.
    Zvanca ME; Bot M; Radu D; Radu N; Petca A
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):604-609. PubMed ID: 28974130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Wright D; Efeturk T; Ceccacci I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):367-372. PubMed ID: 28133831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation.
    Block-Abraham DM; Turan OM; Doyle LE; Kopelman JN; Atlas RO; Jenkins CB; Blitzer MG; Baschat AA
    Obstet Gynecol; 2014 Mar; 123(3):611-617. PubMed ID: 24513777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
    Ortved D; Hawkins TL; Johnson JA; Hyett J; Metcalfe A
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):239-244. PubMed ID: 29700870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening.
    Park F; Russo K; Williams P; Pelosi M; Puddephatt R; Walter M; Leung C; Saaid R; Rawashdeh H; Ogle R; Hyett J
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):419-23. PubMed ID: 25678383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study.
    Ling HZ; Jara PG; Bisquera A; Poon LC; Nicolaides KH; Kametas NA
    BJOG; 2020 Jul; 127(8):1018-1025. PubMed ID: 32133780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation.
    Panaitescu AM; Wright D; Militello A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):383-387. PubMed ID: 28133834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial.
    García B; Llurba E; Valle L; Gómez-Roig MD; Juan M; Pérez-Matos C; Fernández M; García-Hernández JA; Alijotas-Reig J; Higueras MT; Calero I; Goya M; Pérez-Hoyos S; Carreras E; Cabero L
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):680-9. PubMed ID: 26823208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation.
    Wright D; Dragan I; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):194-200. PubMed ID: 27671544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
    Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
    Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for pre-eclampsia at 35-37 weeks' gestation.
    Panaitescu A; Ciobanu A; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):501-506. PubMed ID: 29896778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.